STOCK TITAN

InfuSystem (INFU): AWM reports 2.8% stake, 561,656 shares

InfuSystem Holdings (INFU): AWM Investment Company filed Amendment No. 11 to Schedule 13G reporting beneficial ownership of 561,656 shares of InfuSystem common stock, representing 2.8% of the class.

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

InfuSystem Holdings (INFU): AWM Investment Company filed Amendment No. 11 to Schedule 13G reporting beneficial ownership of 561,656 shares of InfuSystem common stock, representing 2.8% of the class.

AWM reports sole voting and sole dispositive power over these shares. The filing states AWM acts as investment adviser to Special Situations Life Sciences Fund, L.P., which holds the shares. The certification indicates the securities were acquired and are held in the ordinary course of business and not to change or influence control. Item 5 confirms ownership of 5 percent or less of the class. The date of the event requiring the filing is 09/30/2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in INFU does AWM Investment Company report?

AWM reports beneficial ownership of 561,656 shares of InfuSystem common stock, equal to 2.8% of the class.

Is AWM’s INFU stake passive or active?

It is filed on Schedule 13G/A with a certification of ordinary-course ownership, indicating a passive stake.

Who holds the INFU shares and who has voting power?

The shares are held by Special Situations Life Sciences Fund, L.P.; AWM has sole voting and sole dispositive power over 561,656 shares.

What is the date of the reportable event for AWM’s INFU filing?

The date of the event requiring the filing is 09/30/2025.

What is AWM’s filer classification in this 13G/A?

AWM is classified as an Investment Adviser (IA).

Does AWM own more than 5% of INFU?

No. Item 5 confirms ownership of 5 percent or less of the class.

Who signed the filing and when?

The filing was signed by Adam Stettner, Executive Vice President, on 11/13/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Life Sciences Fund, L.P. (SSLS) (SSLS will hereafter be referred to as the Fund). As the investment adviser to the Fund, AWM holds sole voting and investment power over 561,656 Shares.


SCHEDULE 13G



AWM Investment Company, Inc.
Signature:Adam Stettner
Name/Title:Executive Vice President
Date:11/13/2025

Keep reading